X

Trial Profile

Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis in Which Methotrexate (MTX) Treatment is Not Effective

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Theralizumab (Primary)
Indications Rheumatoid arthritis
Focus Adverse reactions
Sponsors TheraMAB

Most Recent Events

17 Feb 2017 Status changed from recruiting to completed.
17 Mar 2014 The first patient was treated at the end of December 2013 according to a TheraMAB media release. Trial pproval was granted by the Ministry of Health of the Russian Federation in October 2013.
17 Mar 2014 Planned number of patients changed from 18 to 120 based on information reported in a TheraMAB media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com